| Authors: |
Lopez-Janeiro A; Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain. Electronic address: alopezj@unav.es., Miraval-Wong E; Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain., Perez-Dominguez P; Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain., Alexandru R; Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain., García Vazquez MG; Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain., Hardisson D; Department of Pathology, Hospital Universitario La Paz, Madrid, Spain; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain; Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital (IdiPAZ), Madrid, Spain; Faculty of Medicine, Universidad Autónoma de Madrid, Spain., Peláez-Garcia A; Proteomics Unit (UCCTs), Instituto de Salud Carlos III, Majadahonda, E-28220 Madrid, Spain., Ruiz-Guillamon D; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Melero I; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Departments of Immunology and Oncology, Clinica Universidad de Navarra, Pamplona, Spain., de Andrea CE; Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain. |
